GM Form 4: Officer exercises options, sells 14,667 shares under 10b5-1 plan
Rhea-AI Filing Summary
General Motors Co. insider Christopher Hatto exercised 14,667 fully vested employee stock options at a $39 exercise price on 08/27/2025 and simultaneously sold 14,667 shares at $59 per share. After the option exercise the filing shows 26,674 shares beneficially owned; after the sale it reports 12,007 shares beneficially owned. The filing indicates the transactions were made pursuant to a written plan intended to satisfy the affirmative defense of Rule 10b5-1(c). The options were originally granted on February 13, 2019 and are fully vested. The Form 4 is signed by an attorney-in-fact on behalf of Mr. Hatto on 08/29/2025.
Positive
- Transactions executed under a Rule 10b5-1(c) written plan, which can provide an affirmative defense to insider trading allegations
- Options were fully vested (granted 02/13/2019), enabling a routine exercise
Negative
- Beneficial ownership decreased from 26,674 shares after exercise to 12,007 shares after the sale, a reduction of 14,667 shares
- Sale of all shares acquired from the exercise (14,667 sold at $59) reduced the reporting person's direct stake
Insights
TL;DR: Officer exercised vested options and sold equal shares, reducing beneficial ownership by 14,667 shares; transactions made under a 10b5-1 plan.
The exercise of 14,667 employee stock options at $39 and immediate sale at $59 generated a per-share spread of $20 before taxes for the reporting person. The net effect on reported holdings moves beneficial ownership from 26,674 to 12,007 shares, a clear decrease in direct ownership by 55% of the post-exercise holdings. Because the filing checks the box for Rule 10b5-1(c), these trades were executed pursuant to a written plan that can provide an affirmative defense to insider trading claims. The transactions are routine for compensatory option exercises and sales and do not include additional material corporate events.
TL;DR: Transactions comply with common governance practices; documented 10b5-1 plan use and attorney-in-fact signature are noted.
The Form 4 documents both an option exercise and an offsetting sale by an officer, and the filer indicated the use of a Rule 10b5-1(c) plan, which aligns with good governance and insider-trading mitigation practices. The filing includes an attorney-in-fact signature dated 08/29/2025, showing formal execution. No other governance or disclosure issues are stated in the filing.